Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 6, 2005, Pages 493-498

  Mehta, Nicholas Y ^a   Ruda, James M ^b   Kapadia, Silloo ^b   Boyer, Phillip J ^c   Hollenbeak, Christopher S ^b,d   Stack, Brendan C ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOARCHITECTURE; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; ORGAN SIZE; PARATHYROID ADENOMA; PARATHYROID CELL; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SCINTISCANNING; THYROID PARAFOLLICULAR CELL; ADENOMA; LABORATORY DIAGNOSIS; PARATHYROID TUMOR; PATHOLOGY;

ADENOMA; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; PARATHYROID NEOPLASMS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 21244505890     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.131.6.493     Document Type: Article

References (27)

1. Lee W-J, Stack BC Jr. Minimally invasive radioguided parathyroidectomy. Otolaryngol Clin North Am. 2004;37:789-798.
2. Parel RJ, Bolton JS, Fuhrman GM. An analysis of sestamibi-positive versus -negative patients with primary hyperparathyroidism. Am Surg. 2001;67:1101-1104.
3. Flynn MB, Bumpous JM, Schill K, McMasters KM. Minimally invasive radioguided parathyroidectomy. J Am Coll Surg. 2000;191:24-31.
4. Staudenherz A, Abela C, Niederle B, et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med. 1997;24:143-149.
5. Denham DW, Norman J. Cost effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure. J Am Coll Surg. 1998;186:293-304.
6. Norman J, Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery. 1997;122:998-1004.
7. Ruda J, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995-2003. Otolaryngol Head Neck Surg. 2005;132:359-372.
8. O'Doherty M, Kettle A, Wells P, Collins R, Coakley AJ. Parathyroid imaging with technetium-99m sestamibi: preoperative localization and tissue uptake studies. J Nucl Med. 1992;33:313-318.
9. Thompson GB, Mullan BP, Grant CS, et al. Parathyroid imaging with technetium-99m-sestamibi: an initial institutional experience. Surgery. 1994;116:966-973.
10. Light VL, McHenry CR, Jarjoura D, Sodee DB, Miron SD. Prospective comparison of dual phase technetium-99m-sestamibi scintigraphy and high resolution ultrasonography in the evaluation of abnormal parathyroid glands. Am Surg. 1996;62:562-568.
11. Taillefer R, Boucher Y, Potvin C, Lamber R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double phase study). J Nucl Med. 1992;33:1801-1807.
12. Klieger P, O'Mara R. The diagnostic utility of dual phase Tc-99m sestamibi parathyroid imaging. Clin Nucl Med. 1998;23:208-211.
13. Benard F, Lefebvre B, Beuvon F, Langlois M, Bisson G. Rapid washout of technetium-99m MIBI from a large parathyroid adenoma. J Nucl Med. 1995;36:241-243.
14. Pinero A, Rodriguez JM, Ortiz S, et al. Relation of biochemical, cytologic, and morphologic parameters to the result of gammagraphy with technetium 99m sestamibi in primary hyperparathyroidism. Otolaryngol Head Neck Surg. 2000;122:851-855.
15. Bhatnagar A, Vezza P, Bryan J, Atkins F, Ziessman H. Technetium-99m sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability. J Nucl Med. 1998;39:1617-1620.
16. Takebayashi S, Hidai H, Chiba T, Takagi Y, Nagatani Y, Matsubara S. Hyperfunctional parathyroid glands with 99mTc-MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med. 1999;40:1792-1797.
17. Chiu ML, Kronage JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium( I) in cultured mouse fibroblasts. J Nucl Med. 1990;31:1646-1653.
18. Carpentier A, Jeanotte S, Verreault J, et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99-MIBI uptake and oxyphil cell content. J Nucl Med. 1998;39:1441-1444.
19. Sandrock D, Merino M, Norton J, Neumann R. Ultrastructural histology correlates with results of thallium-201/technetium-99m parathyroid subtraction scintigraphy. J Nucl Med. 1993;34:24-29.
20. Westreich RW, Brandwein M, Mechanick JI, Bergman DA, Urken ML. Preoperative parathyroid localization: correlating false-negative technetium 99m sestamibi scans with parathyroid disease. Laryngoscope. 2003;113:567-572.
21. Mitchell BK, Cornelius EA, Zoghbi S, et al. Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein. Surgery. 1996;120:1039-1045.
22. Rao VV, Chiu ML, Knonauge KF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med. 1994;35:510-515.
23. Taki J, Sumiya H, Asada N, Ueda Y, Tsuchiya H, Tonami N. Assessment of Pglycoprotein in patients with malignant bone and soft tissue tumors using technetium-99m-MIBI scintigraphy. J Nucl Med. 1998;39:1179-1184.
24. Melloul M, Paz A, Koren R, Cytron S, Feinmesser R, Gal R. 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med. 2001;28:209-213.
25. Biertho LD, Kim C, Wu HS, Unger P, Inabnet WB. Relationship between sestamibi uptake, parathyroid hormone assay, and nuclear morphology in primary hyperparathyroidism. J Am Coll Surg. 2004;199:229-233.
26. Pinero A, Rodriquez JM, Martinez-Barba E, Canteras M, Stiges-Serra A, Parrilla P. Tc99m-sestamibi scintigraphy and cell proliferation in primary hyperparathyroidism: a causal or casual relationship? Surgery. 2003;134:41-44.
27. Yamaguchi S, Yachiku S, Hashimoto H, et al. Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands. World J Surg. 2002;26:29-34.